Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Elekta publ AB's Esteya Gets FDA 510(k) Clearance


Wednesday, 2 Oct 2013 01:30am EDT 

Elekta publ AB announced that the Company's Esteya has received 510(k) clearance from the US Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option. The first installations of Esteya in the United States are scheduled to occur in the next few months. Esteya is an electronic brachytherapy system. 

Company Quote

76.0
4.95 +6.97%
28 Nov 2014